L. Chang

发表

The discovery of sulfonylated dipeptides as potent VLA-4 antagonists.

M. Maccoss, S. D. de Laszlo, J. Fenyk-Melody, 2001, Bioorganic & medicinal chemistry letters.

Binding of thyroxine to pig transthyretin, its cDNA structure, and other properties.

J. Köhrle, B. Southwell, S. Richardson, 1995, European journal of biochemistry.

Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.

K. Jacobson, X. Ji, N. Melman, 1997, Journal of medicinal chemistry.

A Novel Pharmacological Approach to Treating Cardiac Ischemia

K. Jacobson, B. Liang, L. Chang, 2000, The Journal of Biological Chemistry.

A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase.

M. Pike, B. Henderson, L. Kolonel, 1997, Cancer research.

Ipomeanol analogs as chemopreventive agents: effect on the in vitro metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).

S. Amin, D. Desai, J. M. Lin, 1995, Cancer letters.

Synthesis and bioassay of 4-ipomeanol analogs as potential chemopreventive agents against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced tumorigenicity in A/J mice.

S. Amin, D. Desai, L. Chang, 1996, Cancer letters.

Functionalized congeners of 1,4-dihydropyridines as antagonist molecular probes for A3 adenosine receptors.

K. Jacobson, X. Ji, N. Melman, 1999, Bioconjugate chemistry.

Pyrroles and other heterocycles as inhibitors of p38 kinase.

M. Maccoss, B. Frantz, G. Croft, 1998, Bioorganic & medicinal chemistry letters.

Substituted imidazoles as glucagon receptor antagonists.

M. Maccoss, S. O'keefe, S. D. de Laszlo, 2001, Bioorganic & medicinal chemistry letters.

Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.

S. Moro, K. Jacobson, J. Clardy, 1999, Journal of medicinal chemistry.

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

S. Moro, K. Jacobson, A. IJzerman, 1998, Journal of medicinal chemistry.

Evolution of thyroid hormone binding by transthyretins in birds and mammals.

S. Munro, S. Richardson, G. Schreiber, 1999, European journal of biochemistry.

Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity.

W. Greenlee, A. Patchett, P. Chakravarty, 1994, Journal of medicinal chemistry.

In vivo pharmacology of L-159,913, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.

W. Greenlee, P. Siegl, T. W. Schorn, 1995, Clinical and experimental hypertension.

The crystal structure of transthyretin from chicken.

C. Blake, M. Sunde, S. Richardson, 1996, European journal of biochemistry.

Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.

R. Chang, V. J. Lotti, M. Maccoss, 1993, Journal of medicinal chemistry.